IRONWOOD PHARMACEUTICALS ($IRWD) posted quarterly earnings results on Thursday, August 7th. The company reported earnings of $0.14 per share, beating estimates of $0.04 by $0.10. The company also reported revenue of $85,240,000, beating estimates of $61,990,500 by $23,249,500.
You can see Quiver Quantitative's $IRWD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IRONWOOD PHARMACEUTICALS Insider Trading Activity
IRONWOOD PHARMACEUTICALS insiders have traded $IRWD stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $IRWD stock by insiders over the last 6 months:
- THOMAS A MCCOURT (Chief Executive Officer) has made 0 purchases and 2 sales selling 152,417 shares for an estimated $252,497.
- MICHAEL SHETZLINE (SVP, CMO, Head-Res&Drug) sold 41,269 shares for an estimated $72,633
- MINARDO JOHN (Chief Legal Officer) sold 38,938 shares for an estimated $68,530
- GREGORY S. MARTINI (Chief Financial Officer) sold 12,052 shares for an estimated $21,211
- RONALD SILVER (Principal Accounting Officer) sold 12,048 shares for an estimated $21,204
- TAMMI L GASKINS (Chief Commercial Officer) sold 2,563 shares for an estimated $1,486
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
IRONWOOD PHARMACEUTICALS Hedge Fund Activity
We have seen 95 institutional investors add shares of IRONWOOD PHARMACEUTICALS stock to their portfolio, and 121 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 11,158,411 shares (-48.4%) from their portfolio in Q1 2025, for an estimated $16,402,864
- PACER ADVISORS, INC. removed 9,941,673 shares (-84.7%) from their portfolio in Q1 2025, for an estimated $14,614,259
- STATE STREET CORP removed 4,830,528 shares (-58.0%) from their portfolio in Q1 2025, for an estimated $7,100,876
- ARMISTICE CAPITAL, LLC added 4,232,000 shares (+44.7%) to their portfolio in Q1 2025, for an estimated $6,221,040
- MILLENNIUM MANAGEMENT LLC added 4,179,239 shares (+191.7%) to their portfolio in Q1 2025, for an estimated $6,143,481
- VANGUARD GROUP INC removed 3,842,394 shares (-19.7%) from their portfolio in Q1 2025, for an estimated $5,648,319
- JANE STREET GROUP, LLC added 3,092,475 shares (+740.5%) to their portfolio in Q1 2025, for an estimated $4,545,938
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
IRONWOOD PHARMACEUTICALS Price Targets
Multiple analysts have issued price targets for $IRWD recently. We have seen 3 analysts offer price targets for $IRWD in the last 6 months, with a median target of $1.0.
Here are some recent targets:
- Amy Li from Jefferies set a target price of $0.7 on 04/15/2025
- Mohit Bansal from Wells Fargo set a target price of $1.0 on 04/15/2025
- Faisal Khurshid from Leerink Partners set a target price of $1.0 on 04/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
